Grano v. Sodexo, Inc.

District Court, S.D. California·Decided December 3, 2020·No. 3:18-cv-01818·Unknown

Opinion

1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 SOUTHERN DISTRICT OF CALIFORNIA 10 11 VINCENT GRANO, an individual, Case No.: 18-CV-1818 TWR (BLM)

12 Plaintiff, ORDER (1) GRANTING THE 13 v. AMENDING PLAINTIFFS’ MOTION FOR LEAVE TO FILE AMENDED 14 SODEXO MANAGEMENT, INC., a New COMPLAINTS, (2) DENYING AS York Corporation; and CARGILL MEAT 15 MOOT DEFENDANT US FOODS’ SOLUTIONS CORP., a Delaware MOTIONS TO DISMISS, AND 16 Corporation, (3) GRANTING IN PART AND 17 Defendants. DENYING IN PART PLAINTIFFS’ MOTION TO STRIKE 18 AND ALL RELATED CASES 19 (ECF Nos. 184, 187, 191, 194–200, 238)

20 Presently before the Court are several fully briefed motions in these eight 21 consolidated actions:1 Plaintiffs Vincent Grano, Tristan Abbott, Bailey Anderson, Michael 22 23 24 1 On March 9, 2020, the Honorable Gonzalo P. Curiel consolidated the following cases: Abbott v. Sodexo Mgmt., Inc., No. 19-CV-1917 TWR (BLM) (S.D. Cal. filed Oct. 2, 2019); Miller v. Sodexo Mgmt., Inc., 25 No. 19-CV-1909 TWR (BLM) (S.D. Cal. filed Oct. 2, 2019); Lader v. Sodexo Mgmt., Inc., No. 19-CV- 1908 TWR (BLM) (S.D. Cal. filed Oct. 2, 2019); Evers v. Sodexo Mgmt., Inc., No. 19-CV-1907 TWR 26 (BLM) (S.D. Cal. filed Oct. 2, 2019); Browning v. Sodexo Mgmt., Inc., No. 19-CV-1905 TWR (BLM) (S.D. Cal. filed Oct. 2, 2019); Baker v. Sodexo Mgmt., Inc., No. 19-CV-1904 TWR (BLM) (S.D. Cal. filed 27 Oct. 2, 2019); Anderson v. Sodexo Mgmt., Inc., No. 19-CV-1903 TWR (BLM) (S.D. Cal. filed Oct. 2, 28 2019); and Grano v. Sodexo, Inc., No. 18-CV-1818 TWR (BLM) (S.D. Cal. filed Aug. 3, 2018). (See 1 Baker, Hunter Browning, Chase Evers, Conner Lader, and Frank Miller’s Motion to Strike 2 Defendant Sodexo Management, Inc.’s Affirmative Defenses (“Mot. to Strike,” ECF No. 3 187); Amending Plaintiffs Abbott, Anderson, Baker, Browning, Evers, Lader, and Miller’s 4 Motion for Leave Under FRCP 15(a)(2) to File Amended Complaints (“Mot. to Amend,” 5 ECF No. 191); and Defendant US Foods’ Motions to Dismiss Plaintiffs Miller’s, Evers’, 6 Lader’s, Browning’s, Anderson’s, Baker’s, and Abbott’s Second Amended Complaints 7 (ECF Nos. 194–200, respectively, and the “Motions to Dismiss,” collectively). The Court 8 held a hearing on November 20, 2020. (See ECF No. 247.) Having carefully considered 9 Sodexo’s Answer to Plaintiff Grano’s Third Amended Complaint (ECF No. 184 (“Ans.”)), 10 the Amending Plaintiffs’ Proposed Third Amended Complaints (ECF Nos. 191-3–9), the 11 Parties’ arguments, and the law, the Court GRANTS the Amending Plaintiffs’ Motion to 12 Amend, DENIES AS MOOT US Foods’ Motions to Dismiss, and GRANTS IN PART 13 AND DENIES IN PART Plaintiffs’ Motion to Strike, as follows. 14 BACKGROUND 15 I. Escherichia Coli 16 Escherichia coli is a family of bacteria, most members of which do not cause human 17 disease. (ECF No. 191-3 (“Proposed Abbott Compl.”) ¶ 43.2) The E. coli O157:H7 (or 18 “STEC”) strain, however, can cause bloody diarrhea in humans and has a reputation as a 19 significant health hazard. (Id.) 20 E. coli O157:H7 is notable for its extremely low infectious dose, with as few as fifty 21 bacteria capable of causing illness in a child. (Id. ¶ 44.) Approximately two to four days 22 (and up to ten days) after ingestion, (id. ¶ 46), the bacteria attach to the inside surface of 23 the large intestine, where they initiate an inflammatory reaction resulting in vomiting, 24 diarrhea that can be bloody, and abdominal cramps. (Id. ¶¶ 45–46.) E. coli infections 25 range from mild to life-threatening. (See id. ¶ 47.) 26

27 2 Although each of the Amending Plaintiffs has filed his own Proposed Third Amended Complaint, the 28 allegations are substantially similar. (See ECF Nos. 191-3–9.) The Court therefore cites to Tristan 1 Although most cases are mild and resolve within about a week without long-term 2 effects, (id.), approximately ten percent of those infected develop a severe, potentially life- 3 threatening complication called hemolytic uremic syndrome (“HUS”). (See id. ¶ 48.) HUS 4 results in the destruction of red blood cells and platelets in the blood, which can result in 5 clots that occlude the filtering units of the kidneys, leading to acute renal failure. (See id. 6 ¶ 48.) Because antibiotics do not aid in combating E. coli infections, therapy is supportive. 7 (See id. ¶ 47.) There is no known therapy to halt the progression of HUS, which has a 8 mortality rate of approximately five percent. (Id. ¶ 49.) 9 II. October 2017 STEC Outbreak at Camp Pendleton 10 In October 2017, an outbreak of Shiga toxin-producing E. coli O157:H7 and O26 at 11 United States Marine Corps Base Camp Pendleton (Edson Range) and the Marine Corp 12 Recruit Depot sickened at least 244 Marine Corps recruits, including Plaintiffs. (See 13 Proposed Abbott Compl. ¶¶ 8, 10.) Fifteen of those recruits developed HUS. (Id. ¶ 9.) By 14 November 2017, all eight Plaintiffs to these consolidated actions had been hospitalized. 15 (See ECF No. 202 (“US Foods Opp’n”) at 8; see also, e.g., Proposed Abbott Compl. 16 ¶¶ 52–54.) 17 Investigators from multiple public health agencies, including the Centers for Disease 18 Control (“CDC”), conducted studies into the circumstances of the outbreak. (Proposed 19 Abbott Compl. ¶ 12.) The investigators inspected the recruits’ sleep quarters, bathroom 20 facilities, and the cafeterias, (see id.), and interviewed forty-three STEC patients and 135 21 healthy controls and other personnel. (Id. ¶ 13.) 22 The CDC issued its report (the “CDC Report”) on January 23, 2018.3 (See id. ¶ 15.) 23 The CDC Report revealed a statistically significant association between illness and the 24

25 3 The Amending Plaintiffs append a copy of the CDC Report to their Motion to Amend. (See Mot. to 26 Amend Ex. H (ECF No. 191-10.) Because the Amending Plaintiffs refer extensively to the CDC Report in their Proposed Third Amended Complaints and because the CDC Report forms a basis for their claims, 27 the Court may treat the CDC Report as incorporated by reference into the Proposed Third Amended 28 Complaints. See Khoja v. Orexigen Therapeutics, Inc., 899 F.3d 988, 1002–03 (9th Cir. 2018), cert. 1 consumption of undercooked beef. (See id. ¶ 13.) Plaintiffs allege that the STEC- 2 contaminated ground beef patties responsible for the outbreak were served to recruits in 3 the cafeteria on October 21, 2017. (See id. ¶ 18.) 4 Defendant Cargill Meat Solutions Corp. manufactured and produced the patties, (see 5 id.), which were then received, stored, and refrigerated by US Foods prior to distribution 6 to Defendant Sodexo. (See id. ¶ 19.) Sodexo, which is under contract to provide 7 foodservice at all Marine garrisons and mess halls, (see id. ¶¶ 23–25), allegedly prepared 8 undercooked hamburgers and cheeseburgers from the STEC-contaminated ground beef 9 patties on October 21, 2017. (See, e.g., id. ¶ 22.) The recruits began falling ill October 24, 10 2017. (See id. ¶ 11.) 11 III. The Healio Article and Plaintiffs’ Investigation 12 The Amending Plaintiffs allege that they did not learn, and could not have learned, 13 about the conclusions of the CDC Report until April 24, 2018, when an article titled “E. 14 coli outbreak in Marine recruits associated with undercooked beef” was published on the 15 website www.healio.com. (Proposed Abbott Compl. ¶¶ 56, 59.) Plaintiff Grano sent a 16 Freedom of Information Act (“FOIA”) request to the CDC on July 12, 2018. (See id. ¶ 57.) 17 On October 18, 2028, Plaintiffs’ counsel received the CDC Report and other records in 18 response to their FOIA request. (See id.) 19 IV. Procedural Background 20 Plaintiff Grano filed the first of these consolidated lawsuits against Sodexo on 21 August 3, 2018. (See generally ECF No. 1.) On May 30, 2019, Sodexo produced invoices 22 from US Foods to Sodexo in response to Plaintiff Grano’s requests for production of 23 documents. (See Mot.

Free access — add to your briefcase to read the full text and ask questions with AI

Grano v. Sodexo, Inc., (S.D. Cal. 2020).

Grano v. Sodexo, Inc. (Grano v. Sodexo, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Foman v. Davis
371 U.S. 178 (Supreme Court, 1962)
Boyle v. United Technologies Corp.
487 U.S. 500 (Supreme Court, 1988)
Fogerty v. Fantasy, Inc.
510 U.S. 517 (Supreme Court, 1994)
United States v. Berry
618 F.3d 13 (D.C. Circuit, 2010)
United States v. Hiram Webb
655 F.2d 977 (Ninth Circuit, 1981)
Fantasy, Inc. v. Fogerty
984 F.2d 1524 (Ninth Circuit, 1993)
Norgart v. Upjohn Co.
981 P.2d 79 (California Supreme Court, 1999)
Bernson v. Browning-Ferris Industries of California, Inc.
873 P.2d 613 (California Supreme Court, 1994)
Neel v. Magana, Olney, Levy, Cathcart & Gelfand
491 P.2d 421 (California Supreme Court, 1971)
Kassatly v. Yazbeck
734 F. Supp. 13 (District of Columbia, 1990)
Colaprico v. Sun Microsystems, Inc.
758 F. Supp. 1335 (N.D. California, 1991)
Frederick v. Calbio Pharmaceuticals
89 Cal. App. 3d 49 (California Court of Appeal, 1979)
Pereira v. Dow Chemical Co.
129 Cal. App. 3d 865 (California Court of Appeal, 1982)